...
首页> 外文期刊>Rheumatology international. >Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population
【24h】

Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population

机译:Egami评分对预测地中海西部人群川崎病免疫球蛋白抵抗的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Kawasaki disease is an acute self-limited systemic vasculitis common in childhood. Intravenous immunoglobulin (IVIG) is an effective treatment, and it reduces the incidence of cardiac complications. Egami score has been validated to identify IVIG non-responder patients in Japanese population, and it has shown high sensitivity and specificity to identify these non-responder patients. Although its effectiveness in Japan, Egami score has shown to be ineffective in non-Japanese populations. The aim of this study was to apply the Egami score in a Western Mediterranean population in Catalonia (Spain). Observational population-based study that includes patients from all Pediatric Units in 33 Catalan hospitals, both public and private management, between January 2004 and March 2014. Sensitivity and specificity for the Egami score was calculated, and a logistic regression analysis of predictors of overall response to IVIG was also developed. Predicting IVIG resistance with a cutoff for Egami score a parts per thousand yen3 obtained 26 % sensitivity and 82 % specificity. Negative predictive value was 85 % and positive predictive value 22 %. This low sensitivity implies that three out of four non-responders will not be identified by the Egami score. Besides, logistic regression models did not found significance for the use of the Egami score to predict IVIG resistance in Catalan population although having an area under the ROC curve of 0.618 (IC 95 % 0.538-0.698, p < 0.001). Although regression models found an area under the ROC curve > 0.5 to predict IVIG resistance, the low sensitivity excludes the Egami score as a useful tool to predict IVIG resistance in Catalan population.
机译:川崎病是一种常见于儿童的急性自限性全身血管炎。静脉免疫球蛋白(IVIG)是一种有效的治疗方法,可减少心脏并发症的发生率。 Egami评分已被证实可识别日本人群中的IVIG无反应患者,并且已显示出高灵敏度和特异性,可识别这些无反应患者。尽管在日本有效,但Egami评分在非日本人群中却无效。这项研究的目的是将Egami评分应用于加泰罗尼亚(西班牙)的西地中海人口。以人群为基础的观察性研究,其中包括2004年1月至2014年3月之间加泰罗尼亚州33家公立和私立医院所有儿科部门的患者。计算了Egami评分的敏感性和特异性,并对总体反应的预测因子进行了逻辑回归分析还开发了IVIG。以千叶县为基准,对IVIG的抵抗力进行分界,可以得到26%的灵敏度和82%的特异性。阴性预测值为85%,阳性预测值为22%。这种低敏感性意味着Egami得分不会识别出四分之三的无反应者。此外,逻辑回归模型对于使用Egami评分预测加泰罗尼亚人群的IVIG耐药性没有意义,尽管ROC曲线下的面积为0.618(IC 95%0.538-0.698,p <0.001)。尽管回归模型发现ROC曲线下的面积> 0.5可以预测IVIG抵抗力,但低敏感性将Egami评分排除在外,无法预测加泰罗尼亚人群的IVIG抵抗力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号